| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.46 | 3e-15 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.32 | 5e-14 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-12 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-12 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.28 | 9e-12 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-11 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-11 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-10 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-10 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-10 |